O	0	3	The	The	DT	B-NP
B-Multi-tissue_structure	4	14	myoadipose	myoadipose	NN	I-NP
I-Multi-tissue_structure	15	19	flap	flap	NN	I-NP
O	19	20	:	:	:	O
O	21	22	a	a	DT	B-NP
O	23	26	new	new	JJ	I-NP
O	27	36	composite	composite	NN	I-NP
O	36	37	.	.	.	O

O	38	39	A	A	DT	B-NP
O	40	53	prefabricated	prefabricated	JJ	I-NP
B-Multi-tissue_structure	54	63	composite	composite	JJ	I-NP
I-Multi-tissue_structure	64	67	fat	fat	NN	I-NP
I-Multi-tissue_structure	68	72	flap	flap	NN	I-NP
O	73	83	consisting	consist	VBG	B-VP
O	84	86	of	of	IN	B-PP
B-Tissue	87	93	muscle	muscle	NN	B-NP
O	94	99	woven	weave	VBN	B-VP
O	100	104	into	into	IN	B-PP
O	105	107	an	an	DT	B-NP
O	108	120	anatomically	anatomically	RB	I-NP
O	121	129	distinct	distinct	JJ	I-NP
B-Tissue	130	133	fat	fat	JJ	I-NP
I-Tissue	134	137	pad	pad	NN	I-NP
O	138	141	was	be	VBD	B-VP
O	142	149	studied	study	VBN	I-VP
O	150	152	in	in	IN	B-PP
O	153	154	a	a	DT	B-NP
O	155	161	rabbit	rabbit	NN	I-NP
O	162	167	model	model	NN	I-NP
O	167	168	.	.	.	O

O	169	171	In	In	IN	B-PP
O	172	174	17	17	CD	B-NP
O	175	182	rabbits	rabbit	NNS	I-NP
O	182	183	,	,	,	O
O	184	185	a	a	DT	B-NP
O	186	187	2	2	CD	I-NP
O	187	188	-	-	HYPH	I-NP
O	188	190	cm	cm	NN	I-NP
B-Multi-tissue_structure	191	196	strip	strip	NN	I-NP
O	197	199	of	of	IN	B-PP
B-Organ	200	210	latissimus	latissimus	JJ	B-NP
I-Organ	211	216	dorsi	dorsi	NNS	I-NP
O	217	220	was	be	VBD	B-VP
O	221	226	woven	weave	VBN	I-VP
O	227	231	into	into	IN	B-PP
O	232	235	the	the	DT	B-NP
B-Tissue	236	248	parascapular	parascapular	JJ	I-NP
I-Tissue	249	252	fat	fat	JJ	I-NP
I-Tissue	253	256	pad	pad	NN	I-NP
O	257	259	on	on	IN	B-PP
O	260	263	one	one	CD	B-NP
O	264	268	side	side	NN	I-NP
O	268	269	,	,	,	O
O	270	274	with	with	IN	B-PP
O	275	278	the	the	DT	B-NP
B-Tissue	279	292	contralateral	contralateral	JJ	I-NP
I-Tissue	293	296	fat	fat	NN	I-NP
I-Tissue	297	300	pad	pad	NN	I-NP
O	301	308	serving	serve	VBG	B-VP
O	309	311	as	as	IN	B-PP
O	312	313	a	a	DT	B-NP
O	314	321	control	control	NN	I-NP
O	321	322	.	.	.	O

O	323	325	At	At	IN	B-PP
O	326	327	3	3	CD	B-NP
O	328	333	weeks	week	NNS	I-NP
O	333	334	,	,	,	O
O	335	338	the	the	DT	B-NP
O	339	349	endogenous	endogenous	JJ	I-NP
B-Organism_substance	350	355	blood	blood	NN	I-NP
O	356	362	supply	supply	NN	I-NP
O	363	365	of	of	IN	B-PP
O	366	370	both	both	CC	O
O	371	374	the	the	DT	B-NP
O	375	382	control	control	NN	I-NP
O	383	386	and	and	CC	O
O	387	390	the	the	DT	B-NP
O	391	403	experimental	experimental	JJ	I-NP
B-Tissue	404	407	fat	fat	JJ	I-NP
I-Tissue	408	412	pads	pad	NNS	I-NP
O	413	416	was	be	VBD	B-VP
O	417	425	isolated	isolate	VBN	I-VP
O	426	429	and	and	CC	I-VP
O	430	437	ligated	ligate	VBN	I-VP
O	437	438	,	,	,	O
O	439	442	and	and	CC	O
O	443	446	the	the	DT	B-NP
B-Multi-tissue_structure	447	456	composite	composite	JJ	I-NP
I-Multi-tissue_structure	457	460	fat	fat	NN	I-NP
I-Multi-tissue_structure	460	461	/	/	SYM	B-NP
I-Multi-tissue_structure	461	467	muscle	muscle	NN	I-NP
I-Multi-tissue_structure	468	472	flap	flap	NN	I-NP
O	473	476	was	be	VBD	B-VP
O	477	488	transferred	transfer	VBN	I-VP
O	489	491	to	to	TO	B-PP
O	492	495	the	the	DT	B-NP
B-Organism_subdivision	496	501	chest	chest	NN	I-NP
I-Organism_subdivision	502	506	wall	wall	NN	I-NP
O	506	507	.	.	.	O

O	508	510	At	At	IN	B-PP
O	511	512	6	6	CD	B-NP
O	513	518	weeks	week	NNS	I-NP
O	518	519	,	,	,	O
O	520	527	animals	animal	NNS	B-NP
O	528	532	were	be	VBD	B-VP
O	533	539	killed	kill	VBN	I-VP
O	539	540	,	,	,	O
O	541	544	and	and	CC	O
B-Multi-tissue_structure	545	550	flaps	flap	NNS	B-NP
O	551	555	were	be	VBD	B-VP
O	556	564	analyzed	analyze	VBN	I-VP
O	565	568	for	for	IN	B-PP
O	569	575	length	length	NN	B-NP
O	575	576	,	,	,	O
O	577	582	width	width	NN	B-NP
O	582	583	,	,	,	O
O	584	587	and	and	CC	O
O	588	594	weight	weight	NN	B-NP
O	594	595	;	;	:	O
O	596	604	perfused	perfuse	VBN	B-VP
O	605	609	with	with	IN	B-PP
O	610	621	fluorescein	fluorescein	NN	B-NP
O	622	624	or	or	CC	I-NP
O	625	629	lead	lead	NN	I-NP
O	630	635	oxide	oxide	NN	I-NP
O	635	636	;	;	:	O
O	637	640	and	and	CC	O
O	641	649	examined	examine	VBN	B-VP
O	650	664	histologically	histologically	RB	B-ADVP
O	664	665	.	.	.	O

O	666	677	Significant	Significant	JJ	B-NP
O	678	689	differences	difference	NNS	I-NP
O	690	694	were	be	VBD	B-VP
O	695	700	found	find	VBN	I-VP
O	701	708	between	between	IN	B-PP
O	709	712	the	the	DT	B-NP
O	713	720	control	control	NN	I-NP
O	721	724	and	and	CC	O
O	725	737	experimental	experimental	JJ	B-NP
B-Tissue	738	741	fat	fat	JJ	I-NP
I-Tissue	742	746	pads	pad	NNS	I-NP
O	747	751	with	with	IN	B-PP
O	752	758	regard	regard	NN	B-NP
O	759	761	to	to	TO	B-PP
O	762	768	weight	weight	NN	B-NP
O	769	772	and	and	CC	I-NP
O	773	779	length	length	NN	I-NP
O	779	780	.	.	.	O

O	781	793	Experimental	Experimental	JJ	B-NP
B-Multi-tissue_structure	794	799	flaps	flap	NNS	I-NP
O	800	804	were	be	VBD	B-VP
O	805	810	found	find	VBN	I-VP
O	811	813	to	to	TO	I-VP
O	814	816	be	be	VB	I-VP
O	817	825	perfused	perfuse	VBN	I-VP
O	826	831	fully	fully	RB	B-ADVP
O	832	836	with	with	IN	B-PP
O	837	848	fluorescein	fluorescein	NN	B-NP
O	849	852	and	and	CC	I-NP
O	853	857	lead	lead	NN	I-NP
O	858	863	oxide	oxide	NN	I-NP
O	863	864	;	;	:	O
O	865	872	control	control	NN	B-NP
B-Tissue	873	876	fat	fat	JJ	I-NP
I-Tissue	877	881	pads	pad	NNS	I-NP
O	882	886	were	be	VBD	B-VP
O	887	892	found	find	VBN	I-VP
O	893	896	not	not	RB	O
O	897	899	to	to	TO	B-VP
O	900	902	be	be	VB	I-VP
O	903	911	perfused	perfuse	VBN	I-VP
O	911	912	.	.	.	O

O	913	916	The	The	DT	B-NP
O	917	921	lead	lead	NN	I-NP
O	922	927	oxide	oxide	NN	I-NP
O	928	933	group	group	NN	I-NP
O	934	942	revealed	reveal	VBD	B-VP
O	943	952	extensive	extensive	JJ	B-NP
O	953	959	growth	growth	NN	I-NP
O	960	962	of	of	IN	B-PP
B-Multi-tissue_structure	963	968	blood	blood	NN	B-NP
I-Multi-tissue_structure	969	976	vessels	vessel	NNS	I-NP
O	977	981	from	from	IN	B-PP
O	982	985	the	the	DT	B-NP
B-Multi-tissue_structure	986	996	latissimus	latissimus	JJ	I-NP
I-Multi-tissue_structure	997	1002	graft	graft	NN	I-NP
O	1003	1007	into	into	IN	B-PP
O	1008	1011	the	the	DT	B-NP
O	1012	1024	experimental	experimental	JJ	I-NP
B-Tissue	1025	1028	fat	fat	JJ	I-NP
I-Tissue	1029	1032	pad	pad	NN	I-NP
O	1032	1033	.	.	.	O

O	1034	1036	No	No	DT	B-NP
B-Multi-tissue_structure	1037	1044	vessels	vessel	NNS	I-NP
O	1045	1049	were	be	VBD	B-VP
O	1050	1060	visualized	visualize	VBN	I-VP
O	1061	1063	in	in	IN	B-PP
O	1064	1067	the	the	DT	B-NP
O	1068	1076	controls	control	NNS	I-NP
O	1076	1077	.	.	.	O

O	1078	1085	Finally	Finally	RB	B-ADVP
O	1085	1086	,	,	,	O
B-Multi-tissue_structure	1087	1095	sections	section	NNS	B-NP
O	1096	1098	of	of	IN	B-PP
O	1099	1102	the	the	DT	B-NP
O	1103	1110	control	control	NN	I-NP
O	1111	1114	and	and	CC	O
O	1115	1127	experimental	experimental	JJ	B-NP
B-Multi-tissue_structure	1128	1133	flaps	flap	NNS	I-NP
O	1134	1138	were	be	VBD	B-VP
O	1139	1147	analyzed	analyze	VBN	I-VP
O	1148	1162	histologically	histologically	RB	B-ADVP
O	1162	1163	.	.	.	O

O	1164	1165	A	A	DT	B-NP
O	1166	1179	preponderance	preponderance	NN	I-NP
O	1180	1182	of	of	IN	B-PP
O	1183	1189	viable	viable	JJ	B-NP
B-Tissue	1190	1193	fat	fat	NN	I-NP
O	1193	1194	,	,	,	O
O	1195	1199	with	with	IN	B-PP
O	1200	1208	evidence	evidence	NN	B-NP
O	1209	1211	of	of	IN	B-PP
O	1212	1230	neovascularization	neovascularization	NN	B-NP
O	1230	1231	,	,	,	O
O	1232	1235	was	be	VBD	B-VP
O	1236	1241	found	find	VBN	I-VP
O	1242	1244	in	in	IN	B-PP
O	1245	1257	experimental	experimental	JJ	B-NP
B-Multi-tissue_structure	1258	1263	flaps	flap	NNS	I-NP
O	1263	1264	,	,	,	O
O	1265	1273	compared	compare	VBN	B-PP
O	1274	1278	with	with	IN	B-PP
O	1279	1282	the	the	DT	B-NP
O	1283	1291	necrotic	necrotic	JJ	I-NP
B-Tissue	1292	1295	fat	fat	NN	I-NP
O	1296	1300	that	that	WDT	B-NP
O	1301	1314	characterized	characterize	VBD	B-VP
O	1315	1318	the	the	DT	B-NP
O	1319	1327	controls	control	NNS	I-NP
O	1327	1328	.	.	.	O

O	1329	1331	We	We	PRP	B-NP
O	1332	1340	conclude	conclude	VBP	B-VP
O	1341	1345	that	that	IN	B-SBAR
O	1346	1360	prefabrication	prefabrication	NN	B-NP
O	1361	1363	of	of	IN	B-PP
O	1364	1365	a	a	DT	B-NP
B-Multi-tissue_structure	1366	1369	fat	fat	JJ	I-NP
I-Multi-tissue_structure	1370	1374	flap	flap	NN	I-NP
O	1375	1377	is	be	VBZ	B-VP
O	1378	1386	possible	possible	JJ	B-ADJP
O	1387	1390	and	and	CC	O
O	1391	1394	may	may	MD	B-VP
O	1395	1399	have	have	VB	I-VP
O	1400	1409	extensive	extensive	JJ	B-NP
O	1410	1421	application	application	NN	I-NP
O	1422	1424	in	in	IN	B-PP
O	1425	1432	various	various	JJ	B-NP
O	1433	1438	areas	area	NNS	I-NP
O	1439	1441	of	of	IN	B-PP
O	1442	1449	plastic	plastic	NN	B-NP
O	1450	1457	surgery	surgery	NN	I-NP
O	1457	1458	.	.	.	O

